A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency

Biol Chem. 2019 Nov 26;400(12):1603-1616. doi: 10.1515/hsz-2018-0391.

Abstract

In human α1-antitrypsin deficiency, homozygous carriers of the Z (E324K) mutation in the gene SERPINA1 have insufficient circulating α1-antitrypsin and are predisposed to emphysema. Misfolding and accumulation of the mutant protein in hepatocytes also causes endoplasmic reticulum stress and underpins long-term liver damage. Here, we describe transgenic zebrafish (Danio rerio) expressing the wildtype or the Z mutant form of human α1-antitrypsin in hepatocytes. As observed in afflicted humans, and in rodent models, about 80% less α1-antitrypsin is evident in the circulation of zebrafish expressing the Z mutant. Although these zebrafish also show signs of liver stress, they do not accumulate α1-antitrypsin in hepatocytes. This new zebrafish model will provide useful insights into understanding and treatment of α1-antitrypsin deficiency.

Keywords: Danio rerio; SERPINA1; liver; serpin; α1-antitrypsin deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Line
  • Cricetulus
  • Hepatocytes / metabolism*
  • Humans
  • Models, Animal*
  • Mutation
  • Zebrafish
  • alpha 1-Antitrypsin / genetics
  • alpha 1-Antitrypsin / metabolism*
  • alpha 1-Antitrypsin Deficiency / genetics
  • alpha 1-Antitrypsin Deficiency / metabolism*

Substances

  • SERPINA1 protein, human
  • alpha 1-Antitrypsin